Table 8 Apoptotic markers of colon tissue as affected by different treatments.
Group | Caspase 9 | Caspase 3 | Bax | BCL2 | TBARS | |
|---|---|---|---|---|---|---|
Treatments | Sham control | 0.99 ± 0.01d | 1.01 ± 0.105c | 0.99 ± 0.02b | 0.99 ± 0.02b | 7.52 ± 0.4a |
Positive control | 0.15 ± 0.02a | 0.07 ± 0.006a | 0.21 ± 0.02a | 1.254 ± 1.6j | 28.91 ± 2.53c | |
Sericin | 2.09 ± 0.01f. | 2.32 ± 0.006d | 1.39 ± 0.04e | 1.1611 ± 2.9i | 32.05 ± 1.93d | |
Propolis | 1.33 ± 0.03e | 0.77 ± 0.004b | 1.12 ± 0.02c | 1.0836 ± 3.4 h | 34.6 ± 2.41d | |
Sericin/propolis nanoparticles | 3.28 ± 0.05 h | 2.31 ± 0.006d | 1.62 ± 0.01f. | 2.371 ± 1.4f. | 16.6 ± 1.65b | |
Sericin/propolis/fluorouracil NPs | 5.05 ± 0.03j | 4.57 ± 0.003 g | 8.16 ± 0.03i | 5.188 ± 0.05d | 26.6 ± 1.37c | |
Fluorouracil | 3.89 ± 0.01i | 4.26 ± 0.001f. | 5.11 ± 0.02 h | 3.45 ± 0.9e | 24.1 ± 1.92c | |
Prophylactic | Sericin | 0.71 ± 0.03c | 4.21 ± 0.002f. | 1.25 ± 0.05d | 1.771 ± 0.04c | 34.61 ± 1.54d |
Propolis | 0.59 ± 0.02b | 2.77 ± 0.003e | 0.96 ± 0.03b | 0.3135 ± 0.09 g | 31.48 ± 1.32d | |
Sericin/propolis nanoparticles | 2.8 ± 0.02 g | 6.51 ± 0.005 h | 5.01 ± 0.01 g | 0.76 ± 0.02a | 23.58 ± 1.05c | |